Word

IBALTRO

Status

Registered

Status Code

700

Status Date

Tuesday, December 5, 2017

Serial Number

87453741

Registration Number

5350653

Registration Date

Tuesday, December 5, 2017

Mark Type

4000

Filing Date

Wednesday, May 17, 2017

Published for Opposition

Tuesday, September 19, 2017

Trademark Owner History

Glaxo Group Limited - Original Registrant

Classifications

5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Events

Dec 5, 2022

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Nov 8, 2022

Applicant/Correspondence Changes (Non-Responsive) Entered

Nov 8, 2022

Teas Change Of Correspondence Received

Nov 8, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Nov 8, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Nov 8, 2022

Teas Change Of Owner Address Received

Dec 5, 2017

Registered-Principal Register

Sep 19, 2017

Official Gazette Publication Confirmation E-Mailed

Sep 19, 2017

Published For Opposition

Aug 30, 2017

Notification Of Notice Of Publication E-Mailed

Aug 17, 2017

Electronic Record Review Complete

Aug 4, 2017

On Hold - Electronic Record Review Required

Jul 25, 2017

Approved For Pub - Principal Register

Jul 19, 2017

Assigned To Examiner

May 23, 2017

New Application Office Supplied Data Entered In Tram

May 20, 2017

New Application Entered In Tram